­CAPhO Conference 2026

Sponsored Symposia

Thursday, April 23, 2026

11:00 – 12:30
Path Forward: New Approaches for SC Delivery
Session Details
BMS
16:45 – 18:15
Novel Therapeutic Approaches for PIK3CA-mutated, HR+, HER2- Breast Cancer
Sessions Details
Roche
18:30 – 20:00
Zolbetuximab for Gastric/GEJ Cancer: The Role of Allied Health in Administration and Patient Care
Sessions Details
Sponsored Symposium Astellas Pharma Canada Inc.

Friday, April 24, 2026

07:00 – 08:30
Belantamab Mafodotin into the Oncology Pharmacy: Key Considerations for Effective Implementation
Sessions Details
Sponsored Symposium GSK
08:45 – 10:15
Empowering Oncology Pharmacists in Adjuvant CDK4/6 Inhibitor Management
Sessions Details
Sponsored Symposium Novartis
10:30 – 12:00
Redefining Treatment Goals in Polycythemia Vera: From Cytoreduction to Disease Modification
Sessions Details
Sponsored Symposium FORUS Therapeutic Inc.
12:15 – 13:45
Advancing Supportive Care and Treatment Outcomes across the Multiple Myeloma Patient Journey
Sessions Details
Sponsored Symposium Johnson AND Johnson
14:00 – 15:30
Enhancing Patient Outcomes in Bone Health: The Pharmacist's Role in Optimizing Denosumab Use
Sessions Details
AA
15:45 – 17:15
Harnessing Continuous Quality Improvement and Data-Driven Insights to Optimize Smart Infusion Pump Oncology Drug Libraries
Sessions Details
Baxter
17:30 – 19:00
Optimizing Multiple Myeloma Care through Pharmacy Innovation
Sessions Details
Sanofi

Saturday, April 25, 2026

06:45 – 08:15
Integrating Subcutaneous Immunotherapy into our Canadian Pharmacy Practice
Sessions Details
Merck

Sunday, April 26, 2026

07:00 – 08:30
Elevating Practice: Improving Outcomes in Double-Exposed CLL/SLL
Sessions Details
Eli Lilly
12:30 – 14:00
Optimizing the Management of Follicular Lymphoma: An Oncology Pharmacist’s Perspective
Sessions Details
Incyte